Janoff; Andrew
Patent Applications and Registrations
Patent applications and USPTO patent grants for Janoff; Andrew.The latest application filed is for "compositions for delivery of drug combinations".
- Janoff; Andrew - Yardley PA
- Janoff; Andrew - Princeton Junction NJ
| Patent | Date |
|---|---|
| Compositions for delivery of drug combinations Grant 10,722,464 - Tardi , et al. | 2020-07-28 |
| Compositions For Delivery Of Drug Combinations App 20180338917 - TARDI; Paul ; et al. | 2018-11-29 |
| Compositions for delivery of drug combinations Grant 10,058,507 - Tardi , et al. August 28, 2 | 2018-08-28 |
| Compositions For Delivery Of Drug Combinations App 20160113871 - Tardi; Paul ; et al. | 2016-04-28 |
| Compositions for delivery of drug combinations Grant 9,271,931 - Tardi , et al. March 1, 2 | 2016-03-01 |
| Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders Grant 8,092,828 - Louie , et al. January 10, 2 | 2012-01-10 |
| Compositions for delivery of drug combinations Grant 7,850,990 - Tardi , et al. December 14, 2 | 2010-12-14 |
| Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders App 20100303895 - Louie; Arthur ; et al. | 2010-12-02 |
| Fixed ratio drug combination treatments for solid tumors Grant 7,842,676 - Janoff , et al. November 30, 2 | 2010-11-30 |
| Fixed Ratio Drug Combination Treatments For Solid Tumors App 20100189771 - Mayer; Lawrence ; et al. | 2010-07-29 |
| Encapsulation of Bioactive Complexes in Liposomes App 20090068256 - Meers; Paul ; et al. | 2009-03-12 |
| Fixed ratio drug combination treatments for solid tumors App 20090023680 - Janoff; Andrew ; et al. | 2009-01-22 |
| Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders App 20080199515 - Louie; Arthur ; et al. | 2008-08-21 |
| Compositions for Delivery of Drug Combinations App 20070298092 - Tardi; Paul ; et al. | 2007-12-27 |
| Compositions for delivery of drug combinations App 20070148255 - Tardi; Paul ; et al. | 2007-06-28 |
| Modular targeted liposomal delivery system App 20060172003 - Meers; Paul R. ; et al. | 2006-08-03 |
| Compositions for delivery of drug combinations App 20060165771 - Tardi; Paul ; et al. | 2006-07-27 |
| Modular targeted liposomal delivery system Grant 7,060,291 - Meers , et al. June 13, 2 | 2006-06-13 |
| D and L etherlipid stereoisomers and liposomes App 20040047903 - Ahmed, Imran ; et al. | 2004-03-11 |
| D and L etherlipid stereoisomers and liposomes Grant 6,667,053 - Ahmad , et al. December 23, 2 | 2003-12-23 |
| Particulate formulations Grant 6,500,461 - Perkins , et al. December 31, 2 | 2002-12-31 |
| Novel Particulate Formulations App 20020034536 - PERKINS, WALTER ; et al. | 2002-03-21 |
| Peptide-lipid conjugates, liposomes and lipsomal drug delivery Grant 6,339,069 - Meers , et al. January 15, 2 | 2002-01-15 |
| N-acyl phosphatidylethanolamine-mediated liposomal drug delivery Grant 6,294,191 - Meers , et al. September 25, 2 | 2001-09-25 |
| Liposomal peptide-lipid conjugates and delivery using same Grant 6,143,716 - Meers , et al. November 7, 2 | 2000-11-07 |
| N-acyl phosphatidylethanolamine-mediated liposomal drug delivery Grant 6,120,797 - Meers , et al. September 19, 2 | 2000-09-19 |
| Peptide-lipid conjugates Grant 6,087,325 - Meers , et al. July 11, 2 | 2000-07-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 